Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000372916 | SCV000343676 | uncertain significance | not provided | 2016-08-05 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088917 | SCV001009638 | likely benign | Alpha-1-antitrypsin deficiency | 2023-12-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002374482 | SCV002686816 | likely benign | Inborn genetic diseases | 2019-07-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003930165 | SCV004737795 | likely benign | SERPINA1-related disorder | 2022-09-02 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |